# Climb Bio, Inc.: Form SCHEDULE 13D/A, filed Jul 7, 2026

- Company: [Climb Bio, Inc.](/companies/clym.md) (CIK 1768446)
- Form: SCHEDULE 13D/A
- Filed: 2026-07-07
- Accepted by EDGAR: Jul 7, 2026, 16:41 ET
- Period: not reported
- Accession: 0001346824-26-000189
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1768446/000134682426000189/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1768446/000134682426000189/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1768446/000134682426000189/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jul 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001346824-26-000189. Last ingested by Listed: Nov 10, 2026, 04:34 ET. No prices; not investment advice.